Back

Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial.

1 September 2019 (09:42 - 10:00)
Organised by:
Congress Presentation Part of: Treatment of conundrum in acute heart failure Acute Heart Failure ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor David Morrow

Brigham and Women's Hospital, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
State of the Art - TakoTsubo
Doctor J. Ghadri (Greifswald, DE)
Presentation thumbnail
Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trial
Doctor A. Ambrosy (San Francisco, US)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of mineralocorticoid receptor antagonists in patients hospitalized for acute heart failure
Doctor H. Yaku (Suita, JP)
Abstract Slides Video
Presentation thumbnail
A life support based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis ---- a multiple center study
Doctor D. Wang (Nanjing, CN)
Abstract

Access the full session

Session thumbnail
Treatment of conundrum in acute heart failure

The Event

Event poster

ESC Congress 2019

1 September 2019 09:42 CET
You may be interested in
thumbnail
Congress Session
Acute heart failure: what to watch for
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Webinar
Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources